Technical Analysis for ABEO - Abeona Therapeutics Inc.

Grade Last Price % Change Price Change
grade D 7.52 -9.51% -0.79
ABEO closed down 9.51 percent on Friday, March 22, 2019, on 1.52 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical ABEO trend table...

Date Alert Name Type % Chg
Mar 22 Fell Below 20 DMA Bearish 0.00%
Mar 21 Pocket Pivot Bullish Swing Setup -9.51%
Mar 20 Outside Day Range Expansion -4.33%
Mar 20 Down 3 Days in a Row Weakness -4.33%
Mar 19 New Uptrend Bullish -5.29%
Mar 19 Inside Day Range Contraction -5.29%
Mar 18 Earnings Movers Other -7.05%
Mar 15 Pocket Pivot Bullish Swing Setup -7.16%
Mar 15 Earnings Movers Other -7.16%
Mar 14 NR7 Range Contraction 1.35%

Older signals for ABEO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Abeona Therapeutics, Inc., formerly PlasmaTech Biopharmaceuticals, Inc., is focused on developing and delivering gene therapy and plasma-based products for severe and rare diseases. The Company's lead program includes adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome (MPS IIIA and IIIB). Its product pipeline includes ABO-101 (sc AAV9 NAGLU), which is used for the treatment of MPS III B; ABO-102 (sc AAV9 SGSH), which is used for the treatment of MPS III A; ABO-201 (sc AAV9 CLN3), which is used for the treatment of Juvenile Batten Disease (JBD); ABO-301 (AAV LK19 FANCC), which is used for the treatment of Fanconi Anemia (FA), and clustered, regularly interspaced short palindromic repeats/CRISPR associated protein 9 (CRISPR/Cas9) gene editing, which is used for treatment of other rare blood diseases. The Company offers two platforms: Salt Diafiltration (SDF) Process and Polymer Hydrogel Technology (PHT).
Biotechnology Biology Emerging Technologies Gene Therapy Molecular Biology Genetics Genetic Engineering Adeno Associated Virus Genome Editing AAV Cas9 CRISPR Severe And Rare Diseases
Is ABEO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 22.0
52 Week Low 6.26
Average Volume 382,721
200-Day Moving Average 10.6672
50-Day Moving Average 7.134
20-Day Moving Average 7.5605
10-Day Moving Average 7.783
Average True Range 0.4882
ADX 27.03
+DI 26.9717
-DI 15.7761
Chandelier Exit (Long, 3 ATRs ) 6.925400000000001
Chandelier Exit (Short, 3 ATRs ) 7.8146
Upper Bollinger Band 8.3301
Lower Bollinger Band 6.7909
Percent B (%b) 0.47
BandWidth 20.358442
MACD Line 0.2421
MACD Signal Line 0.213
MACD Histogram 0.0291
Fundamentals Value
Market Cap 302.96 Million
Num Shares 40.3 Million
EPS -0.61
Price-to-Earnings (P/E) Ratio -12.33
Price-to-Sales 831.55
Price-to-Book 7.87
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.71
Resistance 3 (R3) 8.82 8.55 8.51
Resistance 2 (R2) 8.55 8.24 8.49 8.44
Resistance 1 (R1) 8.03 8.06 7.90 7.92 8.38
Pivot Point 7.76 7.76 7.69 7.70 7.76
Support 1 (S1) 7.24 7.45 7.11 7.13 6.66
Support 2 (S2) 6.97 7.27 6.91 6.60
Support 3 (S3) 6.45 6.97 6.53
Support 4 (S4) 6.34